ATC代碼 (A03)
外觀
ATC代碼 |
---|
A 消化系統和代謝系統 |
A01 口腔病藥物 (Stomatological preparations) |
A02 治療與胃酸分泌相關疾病的藥物 (Drugs for acid related disorders) |
A03 腸胃機能失調用藥 (Drugs for functional gastrointestinal disorders) |
A04 止吐藥及止噁心藥 (Antiemetics and antinauseants) |
A05 肝、膽疾病治療藥 (Bile and liver therapy) |
A06 輕瀉藥 (Laxatives) |
A07 止瀉藥、腸道消炎藥、腸道抗感染藥 (Antidiarrheals, intestinal anti-inflammatory /anti-infective agents) |
A08 減肥製劑,不包含飲食製品 (Antiobesity preparations, excluding diet products) |
A09 消化藥,包括酶 (Digestives, including enzymes) |
A10 糖尿病用藥 (Drugs used in diabetes) |
A11 維生素 (Vitamins) |
A12 礦物補充劑 (Mineral supplements) |
A13 補藥 (Tonic) |
A14 同化作用藥 (Anabolic agents for systemic use) |
A15 食慾促進劑 (Appetite stimulants) |
A16 其它消化道及新陳代謝用藥 (Other alimentary tract and metabolism products) |
|
ATC代碼A03(治療功能性胃腸疾病的藥物)是解剖學治療學及化學分類系統的一個藥物分組,這是由世界衛生組織藥物統計方法整合中心(The WHO Collaborating Centre for Drug Statistics Methodology)所制定的藥品及其它醫用產品的官方分類系統。分組A03是A消化系統和代謝系統的一部分。[1]
獸用代碼(ATCvet碼)可以在人用ATC代碼前加Q字母:QA03等[2]。沒有相應人用ATC代碼的ATCvet在以下列表中通過前置Q字母表示。
國家ATC分類可能包括列表中沒有的其它分類,列表為世界衛生組織(WHO)版本。
A03A 治療功能性腸道疾病的藥物(Drugs for functional bowel disorders)
[編輯]A03AA 合成的抗膽鹼能藥物,帶叔胺基團的酯類(Synthetic anticholinergics, esters with tertiary amino group)
[編輯]- A03AA01 羥苄利明(Oxyphencyclimine)
- A03AA03 卡米羅芬(Camylofin)
- A03AA04 美貝維林(Mebeverine)
- A03AA05 曲美布汀(Trimebutine)
- A03AA06 羅西維林(Rociverine)
- A03AA07 雙環維林(Dicycloverine)
- A03AA08 雙己維林(Dihexyverine)
- A03AA09 雙苯美林(Difemerine)
- A03AA30 哌立度酯(Piperidolate)
A03AB 合成的抗膽鹼能藥物,季銨鹽化合物類(Synthetic anticholinergics, quaternary ammonium compounds)
[編輯]- A03AB01 苯咯銨(Benzilone)
- A03AB02 格隆銨(Glycopyrronium)
- A03AB03 奧芬銨(Oxyphenonium)
- A03AB04 噴噻銨(Penthienate)
- A03AB05 丙胺太林(Propantheline)
- A03AB06 奧替溴銨(Otilonium bromide)
- A03AB07 甲胺太林(Methantheline)
- A03AB08 曲地銨(Tridihexethyl)
- A03AB09 異丙銨(Isopropamide)
- A03AB10 己環銨(Hexocyclium)
- A03AB11 泊爾定(Poldine)
- A03AB12 美噴酯(Mepenzolate)
- A03AB13 貝弗寧(Bevonium)
- A03AB14 哌噴酯(Pipenzolate)
- A03AB15 二苯馬尼(Diphemanil)
- A03AB16 (2-二苯甲氧乙基)二乙基甲基碘銨((2-benzhydryloxyethyl)diethyl-methylammonium iodide)
- A03AB17 替莫碘胺(Tiemonium iodide)
- A03AB18 吡芬溴銨(Prifinium bromide)
- A03AB19 噻哌溴銨(Timepidium bromide)
- A03AB21 苯維銨(Fenpiverinium)
- A03AB53 奧芬溴銨,複方(Oxyphenonium, combinations)
- QA03AB90 苄替米特(Benzetimide)
- QA03AB92 碳酰膽鹼(Carbachol)
- QA03AB93 新斯的明(Neostigmin)
A03AC 合成的解痙藥,帶叔胺的酰胺類(Synthetic antispasmodics, amides with tertiary amines)
[編輯]- A03AC02 二甲氨基丙基吩噻嗪(Dimethylaminopropionylphenothiazine)
- A03AC04 尼非他胺(Nicofetamide)
- A03AC05 苯酰胺桂胺(Tiropramide)
A03AE 作用於5-羥色胺受體的藥物(Drugs acting on serotonin receptors)
[編輯]- A03AE01 阿洛司瓊(Alosetron)
- A03AE02 替加色羅(Tegaserod)
- A03AE03 西蘭司瓊(Cilansetron)
- A03AE04 普卡必利(Prucalopride)
A03AX 治療功能性腸道疾病的其它藥物(Other drugs for functional bowel disorders)
[編輯]- A03AX01 芬哌丙烷(Fenpiprane)
- A03AX02 地索普明(Diisopromine)
- A03AX03 氯苄沙明(Chlorbenzoxamine)
- A03AX04 匹維銨(Pinaverium)
- A03AX05 非諾維林(Fenoverine)
- A03AX06 依丹帕明(Idanpramine)
- A03AX07 普羅沙唑(Proxazole)
- A03AX08 阿爾維林(Alverine)
- A03AX09 曲匹布通(Trepibutone)
- A03AX10 異美汀(Isometheptene)
- A03AX11 卡羅維林(Caroverine)
- A03AX12 間苯三酚(Phloroglucinol)
- A03AX13 矽氧烷(Silicones),包括西甲矽油(simeticone)
- A03AX30 三甲基二苯丙胺(Trimethyldiphenylpropylamine)
- A03AX58 阿爾維林複方(Alverine, combinations)
- QA03AX63 聚矽酮,複方Silicones, combinations
- QA03AX90 Physiostigmin
- QA03AX91 Macrogol ricinoleat (NFN)
A03B 顛茄及其衍生物(Belladonna and derivatives, plain)
[編輯]A03BA 顛茄生物鹼,叔胺類(Belladonna alkaloids, tertiary amines)
[編輯]A03BB 半合成的顛茄生物鹼,季銨鹽類化合物(Belladonna alkaloids, semisynthetic, quaternary ammonium compounds)
[編輯]- A03BB01 丁基莨菪胺(Butylscopolamine)
- A03BB02 甲基阿托品(Methylatropine)
- A03BB03 甲基莨菪胺(Methylscopolamine)
- A03BB04 芬托銨(Fentonium)
- A03BB05 西托溴銨(Cimetropium bromide)
A03C 複方中有安定藥的解痙藥(Antispasmodics in combination with psycholeptics)
[編輯]A03CA 複方中有安定藥的合成抗膽鹼能藥(Synthetic anticholinergic agents in combination with psycholeptics)
[編輯]- A03CA01 異丙銨和安定藥(Isopropamide and psycholeptics)
- A03CA02 克利銨和安定藥(Clidinium and psycholeptics)
- A03CA03 羥苄利明和安定藥(Oxyphencyclimine and psycholeptics)
- A03CA04 奧替溴銨和安定藥(Otilonium bromide and psycholeptics)
- A03CA05 格隆銨和安定藥(Glycopyrronium and psycholeptics)
- A03CA06 貝弗寧和安定藥(Bevonium and psycholeptics)
- A03CA07 安布溴銨和安定藥(Ambutonium and psycholeptics)
- A03CA08 二苯馬尼和安定藥(Diphemanil and psycholeptics)
- A03CA30 依美銨和安定藥(Emepronium and psycholeptics)
- A03CA34 丙胺太林和安定藥(Propantheline and psycholeptics)
A03CB 複方中有安定藥的顛茄及其衍生物(Belladonna and derivatives in combination with psycholeptics)
[編輯]- A03CB01 甲基莨菪胺和安定藥(Methylscopolamine and psycholeptics)
- A03CB02 顛茄總生物鹼和安定藥(Belladonna total alkaloids and psycholeptics)
- A03CB03 阿托品和安定藥(Atropine and psycholeptics)
- A03CB04 甲基後阿托品和安定藥(Methylhomatropine and psycholeptics)
- A03CB31 莨菪鹼和安定藥(Hyoscyamine and psycholeptics)
A03CC 複方中有安定藥的其它解痙藥(Other antispasmodics in combination with psycholeptics)
[編輯]A03D 複方中有鎮痛藥的其它解痙藥(Antispasmodics in combination with analgesics)
[編輯]A03DA 複方中有鎮痛藥的合成抗膽鹼能藥(Synthetic anticholinergic agents in combination with analgesics)
[編輯]- A03DA01 托齊林和鎮痛藥(Tropenzilone and analgesics)
- A03DA02 吡托非農和鎮痛藥(Pitofenone and analgesics)
- A03DA03 貝弗寧和鎮痛藥(Bevonium and analgesics)
- A03DA04 環隆銨和鎮痛藥(Ciclonium and analgesics)
- A03DA05 卡米羅芬和鎮痛藥(Camylofin and analgesics)
- A03DA06 曲司銨和鎮痛藥(Trospium and analgesics)
- A03DA07 替莫碘胺和鎮痛藥(Tiemonium iodide and analgesics)
A03DB 複方中有鎮痛藥的顛茄及其衍生物(Belladonna and derivatives in combination with analgesics)
[編輯]- A03DB04 丁基莨菪胺和鎮痛藥(Butylscopolamine and analgesics)
A03DC 複方中有鎮痛藥的其它解痙藥(Other antispasmodics in combination with analgesics)
[編輯]A03E 複方中有其它藥物的解痙藥和抗膽鹼能藥(Antispasmodics and anticholinergics in combination with other drugs)
[編輯]A03EA 解痙藥、安定藥和鎮痛藥的複方(Antispasmodics, psycholeptics and analgesics in combination)
[編輯]A03ED 複方中有其它藥物的解痙藥(Antispasmodics in combination with other drugs)
[編輯]A03F 胃腸動力藥(Propulsives)
[編輯]A03FA 胃腸動力藥(Propulsives)
[編輯]- A03FA01 甲氧氯普胺(Metoclopramide)
- A03FA02 西沙必利(Cisapride)
- A03FA03 多潘立酮(嗎叮啉)(Domperidone)
- A03FA04 溴必利(Bromopride)
- A03FA05 阿立必利(Alizapride)
- A03FA06 氯波必利(Clebopride)
- QA03FA90 毒扁豆鹼(Physiostigmine)
參考文獻
[編輯]- ^ ATC Index. WHO Collaborating Centre for Drug Statistics Methodology.
- ^ ATCvet Index. WHO Collaborating Centre for Drug Statistics Methodology.